Immatics (IMTX) EV to CFO (2020 - 2024)
Immatics' EV to CFO came in at 34.69 for Q1 2024, up 53.8% from the prior quarter.
Powered by 
Analysis
Immatics (IMTX) EV to CFO (2020 - 2024) Analysis & Trends
Over the trailing twelve months to Mar 31, 2024, Immatics reported EV to CFO of -108.86; for FY2023, it was 21.85, up 706.0% from FY2022.
- Going back by year, EV to CFO was 2.71 in FY2022 and 2.66 in FY2019 (-76.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Immatics | 1.15 Bn | -890.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 34.69 |
| Dec 31, 2023 | 22.56 |
| Dec 31, 2022 | 2.57 |
| Sep 30, 2022 | 2.66 |
| Jun 30, 2022 | 1.62 |
| Mar 31, 2022 | 5.15 |
| Jun 30, 2020 | 7.94 |
API Access
Immatics EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=IMTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "IMTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=IMTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();